Mark Hunter
Impact in
- Rheumatology top 2%
- GDF15 and Related Biomarkers
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
Papers in
-
- Endometrial and Cervical Cancer Treatments 8
-
- Endometriosis Research and Treatment 5
- Ovarian cancer diagnosis and treatment 4
- Co-authors
- David A. Brown (6 shared papers)Samuel N. Breit (6 shared papers)Bradley J. Monk (5 shared papers)Asne R. Bauskin (3 shared papers)Krishnansu S. Tewari (3 shared papers)Heiko Johnen (2 shared papers)Támara Kuffner (2 shared papers)Xiaohe Luo (1 shared paper)
- Journals
- American Journal of Obstetrics and Gynecology (4 papers)Clinical Cancer Research (2 papers)Cancer Research (2 papers)Journal of Minimally Invasive Gynecology (1 paper)Biomedicines (1 paper)
- Partner nations
- United StatesAustraliaSouth Korea
In The Last Decade
Mark Hunter
29 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 57
- Rheumatology 516
- Obstetrics and Gynecology 156
- Immunology 253
- Reproductive Medicine 98
- Physiology 250
Countries citing papers authored by Mark Hunter
This map shows the geographic impact of Mark Hunter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hunter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hunter more than expected).
Fields of papers citing papers by Mark Hunter
This network shows the impact of papers produced by Mark Hunter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hunter. The network helps show where Mark Hunter may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Hunter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 216 | |
| 2 | 2006 | 180 | |
| 3 | 2005 | 128 | |
| 4 | 2006 | 100 | |
| 5 | 2007 | 84 | |
| 6 | 2008 | 62 | |
| 7 | 2008 | 52 | |
| 8 | 2015 | 51 | |
| 9 | 2010 | 38 | |
| 10 | 2005 | 36 | |
| 11 | 2009 | 28 | |
| 12 | 2004 | 20 | |
| 13 | 2022 | 15 | |
| 14 | A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study | 2015 | 14 |
| 15 | 2019 | 12 | |
| 16 | 2003 | 8 | |
| 17 | 2024 | 8 | |
| 18 | 2007 | 7 | |
| 19 | 2024 | 4 | |
| 20 | 2022 | 4 |
About Mark Hunter
Mark Hunter is a scholar working on Obstetrics and Gynecology, Reproductive Medicine, Immunology, Rheumatology and Public Health, Environmental and Occupational Health, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (8 papers), Endometriosis Research and Treatment (5 papers), GDF15 and Related Biomarkers (5 papers), Ovarian cancer diagnosis and treatment (4 papers), Reproductive System and Pregnancy (3 papers), Nutrition and Health in Aging (3 papers), Cancer Risks and Factors (3 papers) and Macrophage Migration Inhibitory Factor (3 papers). The work is most often cited by research in Rheumatology (516 citations), Obstetrics and Gynecology (156 citations), Immunology (253 citations), Reproductive Medicine (98 citations) and Physiology (250 citations). Mark Hunter has collaborated with scholars based in United States, Australia and South Korea. Frequent co-authors include David A. Brown, Samuel N. Breit, Bradley J. Monk, Asne R. Bauskin, Krishnansu S. Tewari, Heiko Johnen, Támara Kuffner, Xiaohe Luo, Zhen Zhang and Charles J. Yeo. Their work appears in journals such as American Journal of Obstetrics and Gynecology, Clinical Cancer Research, Cancer Research, Journal of Minimally Invasive Gynecology and Biomedicines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.